BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32382328)

  • 1. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
    Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
    Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance.
    Ma YN; Hong YG; Yu GY; Jiang SY; Zhao BL; Guo A; Wang Y; Cui XM; Hao LQ; Zheng H
    Cancer Cell Int; 2021 Sep; 21(1):501. PubMed ID: 34535128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-519d-3p inhibits cell proliferation and migration by targeting TROAP in colorectal cancer.
    Ye X; Lv H
    Biomed Pharmacother; 2018 Sep; 105():879-886. PubMed ID: 30021381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer.
    Wu JB; Li XJ; Liu H; Liu XP
    Biomed Rep; 2023 Jul; 19(1):50. PubMed ID: 37383678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quiescin Sulfhydryl Oxidase 2 Overexpression Predicts Poor Prognosis and Tumor Progression in Patients With Colorectal Cancer: A Study Based on Data Mining and Clinical Verification.
    Jiang T; Zheng L; Li X; Liu J; Song H; Xu Y; Dong C; Liu L; Wang H; Wang S; Wang R; Song J
    Front Cell Dev Biol; 2021; 9():678770. PubMed ID: 34858968
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
    Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
    Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ.
    Tao Y; Ma C; Fan Q; Wang Y; Han T; Sun C
    J Cancer; 2018; 9(13):2317-2326. PubMed ID: 30026827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
    Zhang Y; Zhang Y; Wang J; Yang J; Yang G
    Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer.
    Wu Y; Liang X; Ni J; Zhao R; Shao S; Lu S; Han W; Yu L
    Front Cell Dev Biol; 2021; 9():681240. PubMed ID: 34350177
    [No Abstract]   [Full Text] [Related]  

  • 16. MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAs.
    Castellani G; Buccarelli M; Lulli V; Ilari R; De Luca G; Pedini F; Boe A; Felli N; Biffoni M; Pilozzi E; Marziali G; Ricci-Vitiani L
    Front Oncol; 2022; 12():867886. PubMed ID: 35814429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.
    Zheng GX; Qu AL; Yang YM; Zhang X; Zhang SC; Wang CX
    World J Gastroenterol; 2016 Jun; 22(24):5589-97. PubMed ID: 27350737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
    Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
    J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.
    Qiu G; Zhang XB; Zhang SQ; Liu PL; Wu W; Zhang JY; Dai SR
    Oncol Lett; 2016 Dec; 12(6):5036-5042. PubMed ID: 28101234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.